I-Mab
NASDAQ:IMAB

Watchlist Manager

I-Mab

NASDAQ:IMAB

Watchlist

Dividends

Price: 0.947 USD 0.74% Market Closed

Market Cap: 76.6m USD

Have any thoughts about
I-Mab?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 0.947 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IMAB Alert

I-Mab

0.947

+0.007 (+0.74%)

52 Week Range	0.9397 2.37
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

I-Mab

What unique competitive advantages
does I-Mab hold over its rivals?

What risks and challenges
does I-Mab face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of I-Mab.

What unique competitive advantages
does I-Mab hold over its rivals?

What risks and challenges
does I-Mab face in the near future?

Summarize the latest earnings call
of I-Mab.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for I-Mab.

Provide P/S
for I-Mab.

Provide P/E
for I-Mab.

Provide P/OCF
for I-Mab.

Provide P/FCFE
for I-Mab.

Provide P/B
for I-Mab.

Provide EV/S
for I-Mab.

Provide EV/GP
for I-Mab.

Provide EV/EBITDA
for I-Mab.

Provide EV/EBIT
for I-Mab.

Provide EV/OCF
for I-Mab.

Provide EV/FCFF
for I-Mab.

Provide EV/IC
for I-Mab.

Show me price targets
for I-Mab made by professional analysts.

What are the Revenue projections
for I-Mab?

How accurate were the past Revenue estimates
for I-Mab?

What are the Net Income projections
for I-Mab?

How accurate were the past Net Income estimates
for I-Mab?

What are the EPS projections
for I-Mab?

How accurate were the past EPS estimates
for I-Mab?

What are the EBIT projections
for I-Mab?

How accurate were the past EBIT estimates
for I-Mab?

Compare the revenue forecasts
for I-Mab with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of I-Mab and its key competitors using the latest financial data.

Compare historical revenue growth rates
of I-Mab against its competitors.

Analyze the profit margins
(gross, operating, and net) of I-Mab compared to its peers.

Compare the P/E ratios
of I-Mab against its peers.

Discuss the investment returns and shareholder value creation
comparing I-Mab with its peers.

Analyze the financial leverage
of I-Mab compared to its main competitors.

Show all profitability ratios
for I-Mab.

Provide ROE
for I-Mab.

Provide ROA
for I-Mab.

Provide ROIC
for I-Mab.

Provide ROCE
for I-Mab.

Provide Gross Margin
for I-Mab.

Provide Operating Margin
for I-Mab.

Provide Net Margin
for I-Mab.

Provide FCF Margin
for I-Mab.

Show all solvency ratios
for I-Mab.

Provide D/E Ratio
for I-Mab.

Provide D/A Ratio
for I-Mab.

Provide Interest Coverage Ratio
for I-Mab.

Provide Altman Z-Score Ratio
for I-Mab.

Provide Quick Ratio
for I-Mab.

Provide Current Ratio
for I-Mab.

Provide Cash Ratio
for I-Mab.

What is the historical Revenue growth
over the last 5 years for I-Mab?

What is the historical Net Income growth
over the last 5 years for I-Mab?

What is the current Free Cash Flow
of I-Mab?

Discuss the annual earnings per share (EPS)
trend over the past five years for I-Mab.

IMAB

Balance Sheet

Accounts Receivables

I-Mab
Accounts Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

I-Mab
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

	Accounts Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
I-Mab NASDAQ:IMAB	Accounts Receivables N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Beigene Ltd HKEX:6160	Accounts Receivables ¥2.5B	CAGR 3-Years 86%	CAGR 5-Years 49%	CAGR 10-Years N/A
Akeso Inc HKEX:9926	Accounts Receivables ¥271m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	Accounts Receivables ¥3B	CAGR 3-Years 63%	CAGR 5-Years 74%	CAGR 10-Years N/A
Shanghai RAAS Blood Products Co Ltd SZSE:002252	Accounts Receivables ¥949.9m	CAGR 3-Years 26%	CAGR 5-Years 3%	CAGR 10-Years 25%
Chongqing Zhifei Biological Products Co Ltd SZSE:300122	Accounts Receivables ¥25.5B	CAGR 3-Years 34%	CAGR 5-Years 42%	CAGR 10-Years 50%

No Stocks Found

I-Mab
Glance View

Market Cap

76.6m USD

Industry

Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

Open IMAB Analysis

IMAB Intrinsic Value

0.734 USD

Overvaluation 22%

Intrinsic Value

Price

What is Intrinsic Value?

I-Mab
NASDAQ:IMAB

I-Mab
Accounts Receivables

I-Mab
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

I-Mab
Glance View

See Also

Company

Help

Tools

Stocks

I-Mab NASDAQ:IMAB

I-Mab Accounts Receivables

I-Mab Accounts Receivables Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

I-Mab Glance View

See Also

Company

Help

Tools

Stocks

I-Mab
NASDAQ:IMAB

I-Mab
Accounts Receivables

I-Mab
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

I-Mab
Glance View